Results 311 to 320 of about 9,198,934 (404)
Here, a biointerface membrane engineered with site‐specific interfacial properties is developed. During implantation between gingival and bone defect, the membrane creates a pro‐osteogenic microenvironment, precisely modulates cellular activities at each biointerface, and facilitates the orchestration of complex healing events, ultimately leading to ...
Yuwei Zhu +13 more
wiley +1 more source
Editorial: Vector-based gene delivery in cancer immunotherapy. [PDF]
Cheng N, Yang X, Chen D, Xu C.
europepmc +1 more source
ABSTRACT Engineering living matter has great clinical potential to deliver functional replacement organs. However, clinical translation remains hampered by the current inability to maintain viability of clinically relevant‐sized constructs. During the pre‐vascular phase, implants rely on nutrient diffusion for survival, which is insufficient at ...
Melvin Gurian +5 more
wiley +1 more source
WFS1 gene delivery rescues visual function in a mouse model of Wolfram syndrome
Jagodzinska J +7 more
europepmc +1 more source
A Simple and Safe Protocol for Intra-Testicular Gene Delivery in Neonatal Mice Using a Convenient Isoflurane-Based Anesthesia System. [PDF]
Morohoshi K, Ohba M, Sato M, Nakamura S.
europepmc +1 more source
Growth factor gene delivery for Alzheimer's disease: from animal models to clinical trials
Mark H. Tuszynski +10 more
openalex +1 more source
MagPiezo enables wireless activation of endogenous Piezo1 channels without genetic modification using 19 nm magnetic nanoparticles and low‐intensity magnetic fields. It generates torque forces at the piconewton scale to trigger mechanotransduction in endothelial cells, standing as a novel platform to interrogate and manipulate Piezo1 activity in vitro.
Susel Del Sol‐Fernández +7 more
wiley +1 more source
Protamine-Based Nanotherapeutics for Gene Delivery to Glioblastoma Cells. [PDF]
Barrios-Esteban S +8 more
europepmc +1 more source
xxxx. ABSTRACT Glioblastoma (GBM) remains one of the most lethal brain cancers, with median survival rarely exceeding 15 months after diagnosis. Interleukin‐12 (IL‐12) is a potent immunostimulatory cytokine capable of reshaping the tumor microenvironment (TME), yet its clinical translation is hindered by systemic toxicity and short half‐life. RNA‐based
Fatima Hameedat +11 more
wiley +1 more source

